227 related articles for article (PubMed ID: 22926712)
1. EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma.
Taïeb D; Timmers HJ; Hindié E; Guillet BA; Neumann HP; Walz MK; Opocher G; de Herder WW; Boedeker CC; de Krijger RR; Chiti A; Al-Nahhas A; Pacak K; Rubello D;
Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1977-95. PubMed ID: 22926712
[TBL] [Abstract][Full Text] [Related]
2. Imaging of Pheochromocytomas and Paragangliomas.
Timmers HJLM; Taïeb D; Pacak K; Lenders JWM
Endocr Rev; 2024 May; 45(3):414-434. PubMed ID: 38206185
[TBL] [Abstract][Full Text] [Related]
3. Guidelines to PET measurements of the target occupancy in the brain for drug development.
Takano A; Varrone A; Gulyás B; Salvadori P; Gee A; Windhorst A; Vercouillie J; Bormans G; Lammertsma AA; Halldin C
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2255-2262. PubMed ID: 27514528
[TBL] [Abstract][Full Text] [Related]
4. Nuclear medicine in pheochromocytoma and paraganglioma: at a crossroads with precision medicine.
Taïeb D; Fargette C; Jha A; Pacak K
Endocr Relat Cancer; 2023 Apr; 30(4):. PubMed ID: 36633962
[TBL] [Abstract][Full Text] [Related]
5. EANM recommendations based on systematic analysis of small animal radionuclide imaging in inflammatory musculoskeletal diseases.
Aarntzen EHJG; Noriega-Álvarez E; Artiko V; Dias AH; Gheysens O; Glaudemans AWJM; Lauri C; Treglia G; van den Wyngaert T; van Leeuwen FWB; Terry SYA
EJNMMI Res; 2021 Sep; 11(1):85. PubMed ID: 34487263
[TBL] [Abstract][Full Text] [Related]
6. European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma.
Taïeb D; Hicks RJ; Hindié E; Guillet BA; Avram A; Ghedini P; Timmers HJ; Scott AT; Elojeimy S; Rubello D; Virgolini IJ; Fanti S; Balogova S; Pandit-Taskar N; Pacak K
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2112-2137. PubMed ID: 31254038
[TBL] [Abstract][Full Text] [Related]
7. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.
Lenders JW; Duh QY; Eisenhofer G; Gimenez-Roqueplo AP; Grebe SK; Murad MH; Naruse M; Pacak K; Young WF;
J Clin Endocrinol Metab; 2014 Jun; 99(6):1915-42. PubMed ID: 24893135
[TBL] [Abstract][Full Text] [Related]
8. Current experts' views on precision nuclear medicine imaging of phaeochromocytoma and paraganglioma.
Taïeb D; Pacak K
Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2223-2224. PubMed ID: 31332495
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDOPA PET/CT Imaging of MAX-Related Pheochromocytoma.
Taïeb D; Jha A; Guerin C; Pang Y; Adams KT; Chen CC; Romanet P; Roche P; Essamet W; Ling A; Quezado MM; Castinetti F; Sebag F; Pacak K
J Clin Endocrinol Metab; 2018 Apr; 103(4):1574-1582. PubMed ID: 29534198
[TBL] [Abstract][Full Text] [Related]
10. Guideline for PET/CT imaging of neuroendocrine neoplasms with
Bozkurt MF; Virgolini I; Balogova S; Beheshti M; Rubello D; Decristoforo C; Ambrosini V; Kjaer A; Delgado-Bolton R; Kunikowska J; Oyen WJG; Chiti A; Giammarile F; Sundin A; Fanti S
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1588-1601. PubMed ID: 28547177
[TBL] [Abstract][Full Text] [Related]
11. Endocrinology application of molecular imaging: current role of PET/CT.
Calderoni L; Giovanella L; Fanti S
J Endocrinol Invest; 2024 Jun; ():. PubMed ID: 38837101
[TBL] [Abstract][Full Text] [Related]
12. Tumor metabolism in pheochromocytomas: clinical and therapeutic implications.
Jeeyavudeen MS; Mathiyalagan N; Fernandez James C; Pappachan JM
Explor Target Antitumor Ther; 2024; 5(2):349-373. PubMed ID: 38745767
[TBL] [Abstract][Full Text] [Related]
13. Small Incidental Pheochromocytoma Presenting With Normal or Borderline High 24-hour Urine Fractionated Metanephrines.
Kwek KJH; Yeo CP; Ho BCS; Kon YC
JCEM Case Rep; 2024 Mar; 2(3):luae035. PubMed ID: 38487512
[TBL] [Abstract][Full Text] [Related]
14. Non‑functional paraganglioma: A case report.
Liu Z; Zhang Y; Zhang X; Kong L
Exp Ther Med; 2024 Jan; 27(1):16. PubMed ID: 38125363
[TBL] [Abstract][Full Text] [Related]
15. Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson's Disease: A Comprehensive Review.
Pitton Rissardo J; Fornari Caprara AL
Brain Sci; 2023 Oct; 13(10):. PubMed ID: 37891838
[TBL] [Abstract][Full Text] [Related]
16. Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options.
Eid M; Foukal J; Sochorová D; Tuček Š; Starý K; Kala Z; Mayer J; Němeček R; Trna J; Kunovský L
Cancer Med; 2023 Jul; 12(13):13942-13957. PubMed ID: 37145019
[TBL] [Abstract][Full Text] [Related]
17. Incidental Synchronous
Roshanravan V; Soltani E; Hasanzadeh Haddad E; Sadeghi R; Sahebkari A; Mottaghi M; Aghaee A
Asia Ocean J Nucl Med Biol; 2022; 10(2):138-141. PubMed ID: 35800421
[TBL] [Abstract][Full Text] [Related]
18. [
Prado-Wohlwend S; Del Olmo-García MI; Bello-Arques P; Merino-Torres JF
Front Endocrinol (Lausanne); 2022; 13():778322. PubMed ID: 35197929
[TBL] [Abstract][Full Text] [Related]
19. Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach.
Sarkadi B; Saskoi E; Butz H; Patocs A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163370
[TBL] [Abstract][Full Text] [Related]
20. Progress in the diagnosis and treatment of paraganglioma.
Wang B; Qiu J
Transl Cancer Res; 2019 Nov; 8(7):2624-2635. PubMed ID: 35117020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
